Literature DB >> 11139429

The human prostanoid DP receptor stimulates mucin secretion in LS174T cells.

D H Wright1, A W Ford-Hutchinson, K Chadee, K M Metters.   

Abstract

This study demonstrates the localization of the prostaglandin (PG)D(2) receptor (DP) within the mucous-secreting globlet cells of the human colon by in situ hybridization, which suggests a role for DP in mucous secretion. Selective high affinity ligands were used, therefore, to evaluate DP regulation of mucous secretion in LS174T human colonic adenocarcinoma cells. The expression of hDP in LS174T cells was confirmed at the mRNA level by reverse transcriptase-polymerase chain reaction, and at the protein level by radioligand binding assays and signal transduction (cyclic AMP accumulation) assays. PGD(2) and the highly selective DP-specific agonist L-644,698 ((4-(3-(3-(3-hydroxyoctyl)-4-oxo-2-thiazolidinyl) propyl) benzoic acid) (racemate)), but not PGE(2) competed for [(3)H]-PGD(2)-specific binding to LS174T cell membranes (K:(i) values of 0.4 nM and 7 nM, respectively). The DP-specific agonists PGD(2), PGJ(2), BW245C (5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropylhydantoin)), and L-644,698 showed similar potencies in stimulating cyclic AMP accumulation (EC(50) values: 45 - 90 nM) and demonstrated the expected rank order of potency. PGE(2) also elicited cyclic AMP production in this cell line (EC(50) value: 162 nM). The activation of cyclic AMP production by PGD(2) and L-644,698, but not PGE(2), was inhibited by the selective DP antagonist BW A868C. Thus, PGD(2) and L-644,698 act through hDP in LS174T cells. PGD(2), L-644,698 and PGE(2) (an established mucin secretagogue) potently stimulated mucin secretion in LS174T cells in a concentration-dependent manner (EC(50)<50 nM). However, BW A868C effectively antagonized only the mucin secretion mediated by PGD(2) and L-644,698 and not PGE(2). These data support a role for the DP receptor in the regulation of mucous secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139429      PMCID: PMC1572485          DOI: 10.1038/sj.bjp.0703688

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.

Authors:  D H Wright; K M Metters; M Abramovitz; A W Ford-Hutchinson
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

Review 2.  The biology and pharmacology of PGD2.

Authors:  H Giles; P Leff
Journal:  Prostaglandins       Date:  1988-02

3.  Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor.

Authors:  A Belley; K Chadee
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

4.  The effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of mucin glycoproteins.

Authors:  T E Phillips; C M Stanley; J Wilson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-06       Impact factor: 4.006

5.  Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon.

Authors:  T Frieling; C Rupprecht; A B Kroese; M Schemann
Journal:  Am J Physiol       Date:  1994-01

6.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.

Authors:  M Hirata; A Kakizuka; M Aizawa; F Ushikubi; S Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

7.  Effects of endogenous and exogenous prostaglandins on glycoprotein synthesis and secretion in isolated rabbit gastric mucosa.

Authors:  U Seidler; K Knafla; R Kownatzki; K F Sewing
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

8.  Characterization of quantitative mucin variants from a human colon cancer cell line.

Authors:  S F Kuan; J C Byrd; C B Basbaum; Y S Kim
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

9.  Ca2+-dependent and -independent secretagogue action on gastric mucus secretion in rabbit mucosal explants.

Authors:  U Seidler; K F Sewing
Journal:  Am J Physiol       Date:  1989-04

10.  Prostaglandin E2 alters terminal glycosylation of high molecular weight glycoproteins, released by pig gastric mucous cells in vitro.

Authors:  M L Enss; U Schmidt-Wittig; H K Heim; K F Sewing
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1995-05       Impact factor: 4.006

View more
  11 in total

Review 1.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

Review 2.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

3.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

Authors:  L E M Willemsen; M A Koetsier; S J H van Deventer; E A F van Tol
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

4.  Mucus and adiponectin deficiency: role in chronic inflammation-induced colon cancer.

Authors:  Arpit Saxena; Manjeshwar Shrinath Baliga; Venkatesh Ponemone; Kamaljeet Kaur; Bianca Larsen; Emma Fletcher; Jennifer Greene; Raja Fayad
Journal:  Int J Colorectal Dis       Date:  2013-03-09       Impact factor: 2.571

Review 5.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 6.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 7.  Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.

Authors:  Miriam Peinhaupt; Eva M Sturm; Akos Heinemann
Journal:  Front Med (Lausanne)       Date:  2017-07-19

8.  Schistosomal Lipids Activate Human Eosinophils via Toll-Like Receptor 2 and PGD2 Receptors: 15-LO Role in Cytokine Secretion.

Authors:  Kelly G Magalhães; Tatiana Luna-Gomes; Fabio Mesquita-Santos; Rafael Corrêa; Leonardo Santos Assunção; Georgia Correa Atella; Peter F Weller; Christianne Bandeira-Melo; Patricia T Bozza
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

9.  Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system.

Authors:  Anne-Gaelle Le Loupp; Kalyane Bach-Ngohou; Arnaud Bourreille; Hélène Boudin; Malvyne Rolli-Derkinderen; Marc G Denis; Michel Neunlist; Damien Masson
Journal:  BMC Gastroenterol       Date:  2015-09-04       Impact factor: 3.067

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.